# The Cancer Anorexia-Cachexia Syndrome (CACS) Market is projected to grow to Billion by 2030, experiencing a CAGR of - Published: 2026-11-06 - Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md) - Topics: [News](https://healthcarenews.io/news.md) - Source: https://healthcarenews.io/news/the-cancer-anorexia-cachexia-syndrome-cacs-market-is-projected-to-grow-to-billion-by-2030/ - Publication: Healthcare News - Publisher: Connectively (Terkel, Inc.) - Editorial policy: https://healthcarenews.io/editorial-policy/ [![Cancer Anorexia-Cachexia Syndrome (CACS) Market](https://www.einpresswire.com/image/medium/1239543/cancer-anorexia-cachexia-syndro.jpeg)](https://www.einpresswire.com/image/large/1239543/cancer-anorexia-cachexia-syndro.png#1024x768) Cancer Anorexia-Cachexia Syndrome (CACS) Market *The Business Research Company's Cancer Anorexia-Cachexia Syndrome (CACS) Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035* LONDON, GREATER LONDON, UNITED KINGDOM, November 6, 2026 /[EINPresswire.com](https://www.einpresswire.com/)/ -- "The [cancer anorexia-cachexia syndrome (CACS) market](https://thebusinessresearchcompany.com/report/cancer-anorexia-cachexia-syndrome-cacs-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR) is gaining significant traction as awareness of this complex condition increases alongside rising cancer cases worldwide. This market is poised for substantial growth due to advances in treatment options and supportive care models that address the severe nutritional and metabolic challenges faced by cancer patients. Let’s explore the current market size, key growth drivers, regional dynamics, and emerging trends shaping the future of CACS management. Current Market Size and Expected Growth Trajectory of the Cancer Anorexia-Cachexia Syndrome Market The cancer anorexia-cachexia syndrome market has experienced rapid expansion in recent years. It is projected to grow from $3.88 billion in 2025 to $4.29 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.7%. This historical growth has been fueled by an increasing number of advanced cancer cases, greater recognition of cachexia’s impact on treatment success, earlier use of appetite stimulants in clinics, the rise of hospital-based supportive care initiatives, and expanded research into oncology nutrition. Looking ahead, the market is expected to reach $6.37 billion by 2030, growing at a CAGR of 10.4%. This anticipated expansion is driven by more investments in cachexia drug development, heightened focus on personalized supportive oncology care, increased clinical trials for innovative therapies, broader use of home-based cancer care services, and stronger integration of cachexia management within oncology treatment protocols. Key trends forecasted to influence the market include the development of targeted cachexia therapies, emphasis on anti-inflammatory mechanisms, adoption of combination therapy approaches, growth of nutritional and metabolic support solutions, and a push toward earlier intervention for cachexia. Download a free sample of the cancer anorexia-cachexia syndrome (cacs) market report: [https://thebusinessresearchcompany.com/sample\_request?id=72738524&type=smp&name=Cancer%20Anorexia-Cachexia%20Syndrome%20%28CACS%29%20Market%20Report%202026&utm\_source=EINPresswire&utm\_medium=Paid&utm\_campaign=Nov\_PR](https://thebusinessresearchcompany.com/sample_request?id=72738524&type=smp&name=Cancer%20Anorexia-Cachexia%20Syndrome%20%28CACS%29%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR) Understanding Cancer Anorexia-Cachexia Syndrome and Its Complex Nature Cancer anorexia-cachexia syndrome is a multifaceted complication frequently observed in cancer patients. It is characterized by severe metabolic disruptions involving inflammatory responses, hormonal imbalances, and altered nutrient metabolism. These factors often contribute to a worsened prognosis and increased resistance to cancer treatments, making effective management critical for improving patient outcomes. Increasing Cancer Prevalence as a Primary Growth Factor for the CACS Market The rising incidence of cancer globally is a principal factor driving the expansion of the cancer anorexia-cachexia syndrome market. Cancer encompasses a wide range of diseases marked by uncontrolled cell growth and spread. The global increase in cancer cases is attributed to an aging population, lifestyle changes, environmental factors, advances in detection methods, growing awareness, genetic predispositions, and certain infections linked to cancer development. CACS plays a vital role in addressing the nutritional decline and weight loss commonly seen among cancer patients, thereby enhancing their quality of life and treatment efficacy. For instance, in August 2024, Macmillan Cancer Support reported that over 3 million people in the UK are currently living with cancer, with projections reaching 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. This steady rise in cancer prevalence is a significant driver for the growth of the cancer anorexia-cachexia syndrome market. View the full cancer anorexia-cachexia syndrome (cacs) market report: [https://thebusinessresearchcompany.com/report/cancer-anorexia-cachexia-syndrome-cacs-global-market-report?utm\_source=EINPresswire&utm\_medium=Paid&utm\_campaign=Nov\_PR](https://thebusinessresearchcompany.com/report/cancer-anorexia-cachexia-syndrome-cacs-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR) How Rising Healthcare Spending Supports [Cancer Anorexia-Cachexia Syndrome Market Growth](https://www.thebusinessresearchcompany.com/purchaseoptions?id=21125&slug=cancer-anorexia-cachexia-syndrome-cacs-global-market-report) The increase in healthcare expenditure is another important factor propelling the market forward. Healthcare spending includes both public and private funds allocated to medical services and treatments. Factors such as an aging population, the growing burden of chronic diseases, medical advancements, and demand for higher-quality healthcare contribute to rising expenses. Managing cancer anorexia-cachexia syndrome often requires specialized treatments, nutritional interventions, and palliative care, all of which add to healthcare costs. According to the UK’s Office for National Statistics, healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, a significant jump from the 0.9% increase seen in 2022. This increasing financial commitment to healthcare supports the expansion of the CACS market. Regional Outlook Highlighting Fastest Growth Areas in the Cancer Anorexia-Cachexia Syndrome Market In 2025, North America held the largest share of the [global cancer anorexia-cachexia syndrome market](https://www.thebusinessresearchcompany.com). However, the Asia-Pacific region is expected to exhibit the fastest growth throughout the forecast period. The comprehensive market analysis covers regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on market dynamics and opportunities. Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables. Speak With Our Expert: Saumya Sahay Americas +1 310-496-7795 Asia +44 7882 955267 & +91 8897263534 Europe +44 7882 955267 Email: marketing@tbrc.info The Business Research Company - [www.thebusinessresearchcompany.com](http://www.thebusinessresearchcompany.com) Follow Us On: • LinkedIn: [https://in.linkedin.com/company/the-business-research-company](https://in.linkedin.com/company/the-business-research-company)" Oliver Guirdham The Business Research Company [+44 7882 955267]() [info@tbrc.info](mailto:info@tbrc.info) Visit us on social media: [LinkedIn](https://www.linkedin.com/company/the-business-research-company/) [Facebook](https://www.facebook.com/TheBusinessResearchCompany/) [X](https://twitter.com/tbrc_info) Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. ![](https://www.einpresswire.com/tracking/article.gif?aid=953864971§ion=einpresswire&a=iilkd_i3EjKMKckw&r=Ohkp76qG8AiWTQ6s&i=zqWI11LsLgWYOcKb) ## Related - [Cancer Stem Cells Market Analysis Report Exploring Demand Patterns and Competitive Landscape](https://healthcarenews.io/news/cancer-stem-cells-market-analysis-report-exploring-demand-patterns-and-competitive-landsca.md) - [The Cancer Biopsy Market Is Projected to Experience a Steady 13.3% CAGR Driven by Growing Industry Applications](https://healthcarenews.io/news/the-cancer-biopsy-market-is-projected-to-experience-a-steady-13-3-cagr-driven-by-growing-i.md) - [The Cancer In Vitro Diagnostics (IVD) Market Expected to Grow Rapidly at a 6.7% CAGR Until 2030](https://healthcarenews.io/news/the-cancer-in-vitro-diagnostics-ivd-market-expected-to-grow-rapidly-at-a-6-7-cagr-until-20.md) - [Market Forecast Report for Cancer Treatment Facilities Including Segment Analysis and Strategic Industry Insights](https://healthcarenews.io/news/market-forecast-report-for-cancer-treatment-facilities-including-segment-analysis-and-stra.md)